Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

被引：0
|
作者：
Bin Morya, Marwa [1 ]
Marei, Mohammed A. [2 ]
Tailor, Imran K. [2 ]
Alrajhi, Abdullah M. [3 ]
Alnakhli, Adel [4 ]
Alnajjar, Foud [5 ]
Alnoamani, Mohammed S. [2 ]
Alshehri, Hassan [2 ]
Motabi, Ibraheem H. [2 ]
AlShehry, Nawal [2 ]
Alfayez, Mansour [2 ]
机构：
[1] King Fahad Med City, Hematol Dept, Riyadh, Saudi Arabia
[2] King Fahad Med City, Dept Adult Hematol BMT, Comprehens Canc Ctr, Riyadh, Saudi Arabia
[3] King Fahad Med City, Hematol, Riyadth, Saudi Arabia
[4] King Fahad Med City, Clin Pharm Dept, Riyadh, Saudi Arabia
[5] King Fahad Med City, Riyadh, Saudi Arabia
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4558
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL.
    Sehn, Laurie Helen
    Kamdar, Manali
    Herrera, Alex Francisco
    McMillan, Andrew
    Flowers, Christopher
    Kim, Won Seog
    Kim, Tae Min
    Ozcan, Muhit
    Demeter, Judit
    Hertzberg, Mark
    Trneny, Marek
    Salles, Gilles A.
    Davies, Andrew
    Hirata, Jamie H.
    Cheng, Ji
    Ku, Grace
    Matasar, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S249 - S250
  • [23] CARFILZOMIB TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE
    Uysal, A.
    Ozkan, M. Comert
    Soyer, N. Akad
    Sahin, F.
    Vural, F.
    Tobu, M.
    Tombuloglu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S29 - S30
  • [24] Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Luider, Joanne
    Tay, Jason
    Bahlis, Nizar J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E67 - E68
  • [25] Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience
    Abbasi, Abdul Muqtadir
    Shaikh, Usman
    Ali, Natasha
    Haider, Mohammad Nadir
    LEUKEMIA RESEARCH REPORTS, 2021, 15
  • [26] Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Shingleton, Jennifer R.
    Dave, Sandeep S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 166 - +
  • [27] Relapsed or refractory extranodal DLBCL treated with lenalidomide: A single center study.
    Altavilla, Giuseppe
    Arrigo, Carmela
    Di Mirto, Cristian
    Garufi, Lorenza
    Mondello, Patrizia
    Garipoll, Claudia
    Pitini, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] SALVAGE TREATMENT OF RELAPSED/REFRACTORY (R/R) HODGKIN'S LYMPHOMA (HL): A SINGLE CENTER EXPERIENCE WITH DRUG-CONJUGATED ANTI-CD30 ANTIBODY BRENTUXIMAB VEDOTIN (BV)
    Botto, B.
    Torsello, G.
    Novo, M.
    Santambrogio, E.
    Vassallo, F.
    Evangelista, A.
    Chiappella, A.
    Boccomini, C.
    Orsucci, L.
    Vitolo, U.
    HAEMATOLOGICA, 2019, 104 : 79 - 79
  • [29] SALVAGE REGIMENT WITH FLAT FOR REFRACTORY AND RELAPSED AML: EXPERIENCE A SINGLE CENTRE
    Salamanca, A.
    Madrigal, D.
    Saldana, R.
    Martin, E.
    Garzon, S.
    HAEMATOLOGICA, 2016, 101 : 681 - 681
  • [30] BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE AS A SALVAGE TREATMENT REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
    LaCasce, A.
    Bociek, G.
    Sawas, A.
    Caimi, P.
    Agura, E.
    Matous, J.
    Ansell, S.
    Crosswell, H.
    Islas-Ohlmayer, M.
    Behler, C.
    Cheung, E.
    Forero-Torres, A.
    Vose, J.
    O'Connor, O. A.
    Josephson, N.
    Advani, R.
    HAEMATOLOGICA, 2016, 101 : 45 - 46
12345